NDC Package 33342-003-09 Lamivudine And Zidovudine

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
33342-003-09
Package Description:
60 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Lamivudine And Zidovudine
Non-Proprietary Name:
Lamivudine And Zidovudine
Substance Name:
Lamivudine; Zidovudine
Usage Information:
Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
11-Digit NDC Billing Format:
33342000309
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
60 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 200082 - lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet
  • RxCUI: 200082 - lamivudine 150 MG / zidovudine 300 MG Oral Tablet
  • RxCUI: 200082 - 3TC 150 MG / AZT 300 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Macleods Pharmaceuticals Limited
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Sample Package:
    No
    FDA Application Number:
    ANDA090679
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-30-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 33342-003-09?

    The NDC Packaged Code 33342-003-09 is assigned to a package of 60 tablet in 1 bottle of Lamivudine And Zidovudine, a human prescription drug labeled by Macleods Pharmaceuticals Limited. The product's dosage form is tablet and is administered via oral form.

    Is NDC 33342-003 included in the NDC Directory?

    Yes, Lamivudine And Zidovudine with product code 33342-003 is active and included in the NDC Directory. The product was first marketed by Macleods Pharmaceuticals Limited on August 30, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 33342-003-09?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 33342-003-09?

    The 11-digit format is 33342000309. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-233342-003-095-4-233342-0003-09